RNAimmune is a prominent organization specialized in messenger RNA (mRNA) technology, leveraging over two decades of experience in managing and optimizing this adaptable molecule for medicinal purposes. The core of RNAimmune's exclusive technology involves utilizing mRNA as a vehicle of information to direct the human body in generating its own proteins capable of combating various diseases. The firm employs its methodologies in the advancement of cancer treatments, antibody therapies, rare disease management, and preventive vaccines.